Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) filed its monthly return for the period ending 30 April 2026, indicating no changes to either authorised or issued share capital during the month.

• Authorised share capital stayed at 1.00 billion ordinary shares with a par value of USD 0.05, representing total authorised capital of USD 50.00 million.

• Issued share capital remained unchanged at 557.08 million ordinary shares, with no treasury shares held or created.

• The outstanding public float continues to meet the Main Board’s minimum 25 percent requirement, as confirmed by the company.

• Under the share option scheme adopted on 4 December 2020, 47.28 million options were outstanding at month-end; no options were exercised, and no new shares were issued or transferred.

No warrants, convertible securities, or other equity instruments were reported for the month, underscoring the stability of the company’s capital structure in April 2026.